Contract facts
FederalNo full NAICS 561910 intel page yet. Browse NAICS intelligence
EXPRESS REPORT:764A26266,764A26268,764A26273,764A26274,764A26279,764A26280,764A26285,764A26286,764A26259,764A26260,765C26017,765C26018,770C20017,770C20019,770C26304 is a federal award for National Cmop Office (36C770) held by Aphena Pharma Solutions - Tennessee, LLC. Estimated value $1M ($1M obligated). Current period of performance ends Aug 31, 2022. Place of performance: COOKEVILLE TN.
EXPRESS REPORT:764A26266,764A26268,764A26273,764A26274,764A26279,764A26280,764A26285,764A26286,764A26259,764A26260,765C26017,765C26018,770C20017,770C20019,770C26304
Recompete timing
PublicCurrent PoP ended Aug 31, 2022 (1451 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordAphena Pharma Solutions - Tennessee, LLC — $55.8M obligated across 67 awards (firm-wide, all agencies).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C77022K0144?
36C77022K0144 (Express report:764a26266 764a26268 764a26273) is a National Cmop Office (36C770) award with a potential value of $1M, currently held by Aphena Pharma Solutions - Tennessee, LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C770-22-K-0144?
36C770-22-K-0144 is the dashed form of PIID 36C77022K0144 (Express report:764a26266 764a26268 764a26273), held by Aphena Pharma Solutions - Tennessee, LLC. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C77022K0144?
National Cmop Office (36C770) awarded 36C77022K0144 to Aphena Pharma Solutions - Tennessee, LLC (potential $1M).
Who is the incumbent on 36C77022K0144?
Aphena Pharma Solutions - Tennessee, LLC is the incumbent with $55.8M across 67 related awards in SCOUT’s public footprint. The current period of performance ends Aug 31, 2022.
When does Aphena Pharma Solutions - Tennessee, LLC’s 36C77022K0144 come up for recompete?
SCOUT tracks a period-of-performance end of Aug 31, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.